Megan Peacock’s Post

🎙️🎧 From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II) In this episode, Fierce Pharma's Fraiser Kansteiner sits down with Delara Motlagh, head of cell therapy at Catalent Pharma Solutions; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle, CEO of Germfree. Together, they discuss cell collection, the critical first step in advanced therapy manufacturing, and the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and eventually to the market. Listen below ⬇️🎧 #CellGeneTherapy #CGT #CellandGeneTherapies

🎙️🎧 From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II) In this episode, Fierce Pharma's Fraiser Kansteiner sits down with Delara Motlagh, head of cell therapy at Catalent Pharma Solutions; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle, CEO of Germfree. Together, they discuss cell collection, the critical first step in advanced therapy manufacturing, and the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and eventually to the market. Listen below ⬇️🎧 #CellGeneTherapy #CGT #CellandGeneTherapies

🎙️🎧 From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II) In this episode, Fierce Pharma's Fraiser Kansteiner sits down with Delara Motlagh, head of cell therapy at Catalent Pharma Solutions; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle, CEO of Germfree. Together, they discuss cell collection, the critical first step in advanced therapy manufacturing, and the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and eventually to the market. Listen below ⬇️🎧 #CellGeneTherapy #CGT #CellandGeneTherapies

📅 Mark your calendars! Our first webinar in the 2024 series by eXmoor Pharma kicks off in September. Dive deep into CMC strategies for Cell & Gene Therapy and ensure your pathway from lead to launch is seamless. Register now! https://buff.ly/4dWVyMS #Pharma #CGT #WebinarSeries

Attending American Society of Gene & Cell Therapy Conference next week? Don't forget to check out Theragent (booth 2114) and discover how we can accelerate your GMP manufacturing success in advanced therapies. #ASGCT2024 #advancedtherapies #geneandcelltherapy #Theragent

Want to hear more about negotiating cell and gene therapy deals? We’ve got a great panel line up on 5 June so do sign up to hear more about their experiences when CGT licensing and collaboration agreements, investment rounds and more. I’m really looking forward to chairing this discussion! 😀🧬🏥 #bristowsllp, #onenucleus, #cellandgene, #intellectualproperty, #lifesciences

Don’t forget to attend our sponsored session at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting on Friday, May 10 from 8-8:30 a.m. EDT. This session will cover how strategic collaborations between #CDMOs and #CROs are addressing industry challenges related to #viralvector production, leading to: - Improved AAV production titer with a significant reduction in cost of goods via high-throughput processes and analytical development - Direct scale-up from bench to 2,000L - Strategies for enhancing % full enrichment during downstream processing - Developing customer-centric analytics for viral vector characterization in development and GMP settings Learn more about this sponsored session here: http://spr.ly/6047jdT23

Regenerative medicine is not a distant reality—it's a transformative force that's shaping the world of medicinal therapeutics today. At Two Labs, we’ve proudly guided manufacturers from the earliest stages of pre-clinical development through to the life-changing patient outcomes that follow. If you missed our latest insights on the current state of the cell and gene therapy pipeline, we've made it easy to catch up. Check out our comprehensive webinar recap that charts the progress and previews the breakthroughs on the horizon. Start with the blog here and access the full webinar within for a full recap of where the pipeline stands. https://bit.ly/48wftyD

Are we ready to deliver therapies to patients quickly and efficiently? How can we address challenges of new modalities' needs? Listen my podcast where I share my view on how to pave the way for an industry alignment to deliver best practices in clinical and commercial outbound supply chains. #cellandgenetherapy #cgt #advancedtherapies #supplychainmanagement #sartorius

Are you going to the American Society of Gene & Cell Therapy (#ASGCT) 27th Annual Meeting in #Baltimore, Maryland from May 7-11? If so, be sure to attend Thermo Fisher Scientific's sponsored session on Friday, May 10 at 8 a.m. EDT: “Revolutionizing #genetherapy services: A synergistic approach to analytics and scaling up through CDMO-CRO collaboration.” This session will explore the possibilities of adeno-associated viral (#AAV) vectors as widely-used carriers for #genetherapy medicinal products (#GTMPs). It will also discuss the challenges in #scalability and #analytics during AAV production that may limit their impact. Additionally, it will cover how strategic CDMO-CRO collaborations can help address these hurdles. Learn more about this sponsored session here: http://spr.ly/6044brBXa